Myelodysplastic syndrome evolving from aplastic anemia treated with

Patients’ and disease characteristics in myelodysplastic syndrome patients evolving from aplastic anemia (post-AA MDS)

Transplant characteristics in patients with post-AA MDS and de novo MDS. Sung-Yong Kim et

Cumulative incidence of acute (A) and chronic (B) graft-versus-host disease in post aplastic anemia

Probability of relapse (A), non-relapse mortality (B), relapse-free survival (C) and overall survival (D)

Multivariate analysis of prognostic factors for transplant outcomes. Sung-Yong Kim et al. Haematologica 2014;

Causes of non-relapse mortality among post-AA MDS and de novo MDS patients. Sung-Yong Kim

Cytogenetics as prognostic factor for overall survival (subgroup analysis). Sung-Yong Kim et al. Haematologica

Slides: 8

Download presentation

Myelodysplastic syndrome evolving from aplastic anemia treated with immunosuppressive therapy: efficacy of hematopoietic stem cell transplantation by Sung-Yong Kim, Jennifer Le Rademacher, Joseph H. Antin, Paolo Anderlini, Mouhab Ayas, Minoo Battiwalla, Jeanette Carreras, Joanne Kurtzberg, Ryotaro Nakamura, Mary Eapen, and H. Joachim Deeg haematol Volume 99(12): 1868 -1875 December 3, 2014 © 2014 by Ferrata Storti Foundation

Patients’ and disease characteristics in myelodysplastic syndrome patients evolving from aplastic anemia (post-AA MDS) and de novo MDS patients for matched pair analysis. Sung-Yong Kim et al. Haematologica 2014; 99: 1868 -1875 © 2014 by Ferrata Storti Foundation

Cumulative incidence of acute (A) and chronic (B) graft-versus-host disease in post aplastic anemia myelodysplastic syndrome and de novo myelodysplastic syndrome patients after allogeneic hematopoietic stem cell transplantation. Sung-Yong Kim et al. Haematologica 2014; 99: 1868 -1875 © 2014 by Ferrata Storti Foundation

Probability of relapse (A), non-relapse mortality (B), relapse-free survival (C) and overall survival (D) of post aplastic anemia myelodysplastic syndrome and de novo myelodysplastic syndrome patients after allogeneic hematopoietic stem cell transplantation. Sung-Yong Kim et al. Haematologica 2014; 99: 1868 -1875 © 2014 by Ferrata Storti Foundation